 | • レポートコード：D0804-16399 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、121ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ピロキシカムの世界市場を広く調査・分析し、今後の市場展望をまとめております。ピロキシカムの種類別市場規模（坐剤、注射剤、カプセル剤、貼付剤、その他）、用途別市場規模（腱炎、全身性外傷性疼痛、筋骨格痛、避妊、関節リウマチ、慢性感染性関節炎、変形性関節症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、JUMPCAN、Nostrum、Teva、JINGHUA、Mylan、Apotex Corporation、FANGMING、DCPC、Technilab Pharma、Chiesi、APR、Keltman Pharmaceuticals、SkyePharma、SK Chemicals、PLX Pharma、Genpharm、CJ HealthCare、Bioglan Laboratories、Bayer、Changzhou Siyao Pharmaceutical、Shanxi Yunpeng Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・ピロキシカムの北米市場（アメリカ、カナダ、メキシコ） ・ピロキシカムのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ピロキシカムのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ピロキシカムの南米市場（ブラジル、アルゼンチン） ・ピロキシカムの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：坐剤、注射剤、カプセル剤、貼付剤、その他 ・用途別分析：腱炎、全身性外傷性疼痛、筋骨格痛、避妊、関節リウマチ、慢性感染性関節炎、変形性関節症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Piroxicam market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Piroxicam market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Piroxicam market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Piroxicam market has been segmented into:
Suppositories
Injection
Capsule
Patch
Other
By Application, Piroxicam has been segmented into:
Tendonitis
Systemic Traumatic Pain
Musculoskeletal Pain
Contraception
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Piroxicam market presented in the report. This section sheds light on the sales growth of different regional and country-level Piroxicam markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Piroxicam market.
The report offers in-depth assessment of the growth and other aspects of the Piroxicam market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Piroxicam Market Share Analysis
Piroxicam competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Piroxicam sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Piroxicam sales, revenue and market share for each player covered in this report.
The major players covered in Piroxicam are:
Pfizer
JUMPCAN
Nostrum
Teva
JINGHUA
Mylan
Apotex Corporation
FANGMING
DCPC
Technilab Pharma
Chiesi
APR
Keltman Pharmaceuticals
SkyePharma
SK Chemicals
PLX Pharma
Genpharm
CJ HealthCare
Bioglan Laboratories
Bayer
Changzhou Siyao Pharmaceutical
Shanxi Yunpeng Pharmaceutical
1 Piroxicam Market Overview
1.1 Product Overview and Scope of Piroxicam
1.2 Classification of Piroxicam by Type
1.2.1 Global Piroxicam Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Piroxicam Revenue Market Share by Type in 2019
1.2.3 Suppositories
1.2.4 Injection
1.2.5 Capsule
1.2.6 Patch
1.2.7 Other
1.3 Global Piroxicam Market by Application
1.3.1 Overview: Global Piroxicam Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tendonitis
1.3.3 Systemic Traumatic Pain
1.3.4 Musculoskeletal Pain
1.3.5 Contraception
1.3.6 Rheumatoid Arthritis
1.3.7 Chronic Infectious Arthritis
1.3.8 Osteoarthritis
1.3.9 Other
1.4 Global Piroxicam Market by Regions
1.4.1 Global Piroxicam Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Piroxicam (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Piroxicam Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Piroxicam Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Piroxicam Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Piroxicam Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Piroxicam Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.2 JUMPCAN
2.2.1 JUMPCAN Details
2.2.2 JUMPCAN Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 JUMPCAN SWOT Analysis
2.2.4 JUMPCAN Product and Services
2.2.5 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nostrum
2.3.1 Nostrum Details
2.3.2 Nostrum Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nostrum SWOT Analysis
2.3.4 Nostrum Product and Services
2.3.5 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.5 JINGHUA
2.5.1 JINGHUA Details
2.5.2 JINGHUA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 JINGHUA SWOT Analysis
2.5.4 JINGHUA Product and Services
2.5.5 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.7 Apotex Corporation
2.7.1 Apotex Corporation Details
2.7.2 Apotex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Apotex Corporation SWOT Analysis
2.7.4 Apotex Corporation Product and Services
2.7.5 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.8 FANGMING
2.8.1 FANGMING Details
2.8.2 FANGMING Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 FANGMING SWOT Analysis
2.8.4 FANGMING Product and Services
2.8.5 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.9 DCPC
2.9.1 DCPC Details
2.9.2 DCPC Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 DCPC SWOT Analysis
2.9.4 DCPC Product and Services
2.9.5 DCPC Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.10 Technilab Pharma
2.10.1 Technilab Pharma Details
2.10.2 Technilab Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Technilab Pharma SWOT Analysis
2.10.4 Technilab Pharma Product and Services
2.10.5 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.11 Chiesi
2.11.1 Chiesi Details
2.11.2 Chiesi Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Chiesi SWOT Analysis
2.11.4 Chiesi Product and Services
2.11.5 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.12 APR
2.12.1 APR Details
2.12.2 APR Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 APR SWOT Analysis
2.12.4 APR Product and Services
2.12.5 APR Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.13 Keltman Pharmaceuticals
2.13.1 Keltman Pharmaceuticals Details
2.13.2 Keltman Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Keltman Pharmaceuticals SWOT Analysis
2.13.4 Keltman Pharmaceuticals Product and Services
2.13.5 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.14 SkyePharma
2.14.1 SkyePharma Details
2.14.2 SkyePharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 SkyePharma SWOT Analysis
2.14.4 SkyePharma Product and Services
2.14.5 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.15 SK Chemicals
2.15.1 SK Chemicals Details
2.15.2 SK Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 SK Chemicals SWOT Analysis
2.15.4 SK Chemicals Product and Services
2.15.5 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.16 PLX Pharma
2.16.1 PLX Pharma Details
2.16.2 PLX Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 PLX Pharma SWOT Analysis
2.16.4 PLX Pharma Product and Services
2.16.5 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.17 Genpharm
2.17.1 Genpharm Details
2.17.2 Genpharm Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Genpharm SWOT Analysis
2.17.4 Genpharm Product and Services
2.17.5 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.18 CJ HealthCare
2.18.1 CJ HealthCare Details
2.18.2 CJ HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 CJ HealthCare SWOT Analysis
2.18.4 CJ HealthCare Product and Services
2.18.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.19 Bioglan Laboratories
2.19.1 Bioglan Laboratories Details
2.19.2 Bioglan Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Bioglan Laboratories SWOT Analysis
2.19.4 Bioglan Laboratories Product and Services
2.19.5 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.20 Bayer
2.20.1 Bayer Details
2.20.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Bayer SWOT Analysis
2.20.4 Bayer Product and Services
2.20.5 Bayer Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.21 Changzhou Siyao Pharmaceutical
2.21.1 Changzhou Siyao Pharmaceutical Details
2.21.2 Changzhou Siyao Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Changzhou Siyao Pharmaceutical SWOT Analysis
2.21.4 Changzhou Siyao Pharmaceutical Product and Services
2.21.5 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
2.22 Shanxi Yunpeng Pharmaceutical
2.22.1 Shanxi Yunpeng Pharmaceutical Details
2.22.2 Shanxi Yunpeng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Shanxi Yunpeng Pharmaceutical SWOT Analysis
2.22.4 Shanxi Yunpeng Pharmaceutical Product and Services
2.22.5 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Piroxicam Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Piroxicam Players Market Share
3.2.2 Top 10 Piroxicam Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Piroxicam Revenue and Market Share by Regions
4.2 North America Piroxicam Revenue and Growth Rate (2015-2020)
4.3 Europe Piroxicam Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Piroxicam Revenue and Growth Rate (2015-2020)
4.5 South America Piroxicam Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Piroxicam Revenue and Growth Rate (2015-2020)
5 North America Piroxicam Revenue by Countries
5.1 North America Piroxicam Revenue by Countries (2015-2020)
5.2 USA Piroxicam Revenue and Growth Rate (2015-2020)
5.3 Canada Piroxicam Revenue and Growth Rate (2015-2020)
5.4 Mexico Piroxicam Revenue and Growth Rate (2015-2020)
6 Europe Piroxicam Revenue by Countries
6.1 Europe Piroxicam Revenue by Countries (2015-2020)
6.2 Germany Piroxicam Revenue and Growth Rate (2015-2020)
6.3 UK Piroxicam Revenue and Growth Rate (2015-2020)
6.4 France Piroxicam Revenue and Growth Rate (2015-2020)
6.5 Russia Piroxicam Revenue and Growth Rate (2015-2020)
6.6 Italy Piroxicam Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Piroxicam Revenue by Countries
7.1 Asia-Pacific Piroxicam Revenue by Countries (2015-2020)
7.2 China Piroxicam Revenue and Growth Rate (2015-2020)
7.3 Japan Piroxicam Revenue and Growth Rate (2015-2020)
7.4 Korea Piroxicam Revenue and Growth Rate (2015-2020)
7.5 India Piroxicam Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Piroxicam Revenue and Growth Rate (2015-2020)
8 South America Piroxicam Revenue by Countries
8.1 South America Piroxicam Revenue by Countries (2015-2020)
8.2 Brazil Piroxicam Revenue and Growth Rate (2015-2020)
8.3 Argentina Piroxicam Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Piroxicam by Countries
9.1 Middle East & Africa Piroxicam Revenue by Countries (2015-2020)
9.2 Saudi Arabia Piroxicam Revenue and Growth Rate (2015-2020)
9.3 UAE Piroxicam Revenue and Growth Rate (2015-2020)
9.4 Egypt Piroxicam Revenue and Growth Rate (2015-2020)
9.5 South Africa Piroxicam Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Piroxicam Revenue and Market Share by Type (2015-2020)
10.2 Global Piroxicam Market Forecast by Type (2019-2024)
10.3 Suppositories Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
10.5 Capsule Revenue Growth Rate (2015-2025)
10.6 Patch Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Piroxicam Market Segment by Application
11.1 Global Piroxicam Revenue Market Share by Application (2015-2020)
11.2 Piroxicam Market Forecast by Application (2019-2024)
11.3 Tendonitis Revenue Growth (2015-2020)
11.4 Systemic Traumatic Pain Revenue Growth (2015-2020)
11.5 Musculoskeletal Pain Revenue Growth (2015-2020)
11.6 Contraception Revenue Growth (2015-2020)
11.7 Rheumatoid Arthritis Revenue Growth (2015-2020)
11.8 Chronic Infectious Arthritis Revenue Growth (2015-2020)
11.9 Osteoarthritis Revenue Growth (2015-2020)
11.10 Other Revenue Growth (2015-2020)
12 Global Piroxicam Market Size Forecast (2021-2025)
12.1 Global Piroxicam Market Size Forecast (2021-2025)
12.2 Global Piroxicam Market Forecast by Regions (2021-2025)
12.3 North America Piroxicam Revenue Market Forecast (2021-2025)
12.4 Europe Piroxicam Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Piroxicam Revenue Market Forecast (2021-2025)
12.6 South America Piroxicam Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Piroxicam Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Piroxicam Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Piroxicam by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Piroxicam Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Piroxicam Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Piroxicam Major Business
Table 7. Pfizer Piroxicam Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Piroxicam Product and Solutions
Table 10. Pfizer Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. JUMPCAN Corporate Information, Location and Competitors
Table 12. JUMPCAN Piroxicam Major Business
Table 13. JUMPCAN Piroxicam Total Revenue (USD Million) (2018-2019)
Table 14. JUMPCAN SWOT Analysis
Table 15. JUMPCAN Piroxicam Product and Solutions
Table 16. JUMPCAN Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Nostrum Corporate Information, Location and Competitors
Table 18. Nostrum Piroxicam Major Business
Table 19. Nostrum Piroxicam Total Revenue (USD Million) (2017-2018)
Table 20. Nostrum SWOT Analysis
Table 21. Nostrum Piroxicam Product and Solutions
Table 22. Nostrum Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Teva Corporate Information, Location and Competitors
Table 24. Teva Piroxicam Major Business
Table 25. Teva Piroxicam Total Revenue (USD Million) (2017-2018)
Table 26. Teva SWOT Analysis
Table 27. Teva Piroxicam Product and Solutions
Table 28. Teva Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. JINGHUA Corporate Information, Location and Competitors
Table 30. JINGHUA Piroxicam Major Business
Table 31. JINGHUA Piroxicam Total Revenue (USD Million) (2017-2018)
Table 32. JINGHUA SWOT Analysis
Table 33. JINGHUA Piroxicam Product and Solutions
Table 34. JINGHUA Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Mylan Corporate Information, Location and Competitors
Table 36. Mylan Piroxicam Major Business
Table 37. Mylan Piroxicam Total Revenue (USD Million) (2017-2018)
Table 38. Mylan SWOT Analysis
Table 39. Mylan Piroxicam Product and Solutions
Table 40. Mylan Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Apotex Corporation Corporate Information, Location and Competitors
Table 42. Apotex Corporation Piroxicam Major Business
Table 43. Apotex Corporation Piroxicam Total Revenue (USD Million) (2017-2018)
Table 44. Apotex Corporation SWOT Analysis
Table 45. Apotex Corporation Piroxicam Product and Solutions
Table 46. Apotex Corporation Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. FANGMING Corporate Information, Location and Competitors
Table 48. FANGMING Piroxicam Major Business
Table 49. FANGMING Piroxicam Total Revenue (USD Million) (2017-2018)
Table 50. FANGMING SWOT Analysis
Table 51. FANGMING Piroxicam Product and Solutions
Table 52. FANGMING Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. DCPC Corporate Information, Location and Competitors
Table 54. DCPC Piroxicam Major Business
Table 55. DCPC Piroxicam Total Revenue (USD Million) (2017-2018)
Table 56. DCPC SWOT Analysis
Table 57. DCPC Piroxicam Product and Solutions
Table 58. DCPC Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Technilab Pharma Corporate Information, Location and Competitors
Table 60. Technilab Pharma Piroxicam Major Business
Table 61. Technilab Pharma Piroxicam Total Revenue (USD Million) (2017-2018)
Table 62. Technilab Pharma SWOT Analysis
Table 63. Technilab Pharma Piroxicam Product and Solutions
Table 64. Technilab Pharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Chiesi Corporate Information, Location and Competitors
Table 66. Chiesi Piroxicam Major Business
Table 67. Chiesi Piroxicam Total Revenue (USD Million) (2017-2018)
Table 68. Chiesi SWOT Analysis
Table 69. Chiesi Piroxicam Product and Solutions
Table 70. Chiesi Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. APR Corporate Information, Location and Competitors
Table 72. APR Piroxicam Major Business
Table 73. APR Piroxicam Total Revenue (USD Million) (2017-2018)
Table 74. APR SWOT Analysis
Table 75. APR Piroxicam Product and Solutions
Table 76. APR Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Keltman Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Keltman Pharmaceuticals Piroxicam Major Business
Table 79. Keltman Pharmaceuticals Piroxicam Total Revenue (USD Million) (2017-2018)
Table 80. Keltman Pharmaceuticals SWOT Analysis
Table 81. Keltman Pharmaceuticals Piroxicam Product and Solutions
Table 82. Keltman Pharmaceuticals Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. SkyePharma Corporate Information, Location and Competitors
Table 84. SkyePharma Piroxicam Major Business
Table 85. SkyePharma Piroxicam Total Revenue (USD Million) (2017-2018)
Table 86. SkyePharma SWOT Analysis
Table 87. SkyePharma Piroxicam Product and Solutions
Table 88. SkyePharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. SK Chemicals Corporate Information, Location and Competitors
Table 90. SK Chemicals Piroxicam Major Business
Table 91. SK Chemicals Piroxicam Total Revenue (USD Million) (2017-2018)
Table 92. SK Chemicals SWOT Analysis
Table 93. SK Chemicals Piroxicam Product and Solutions
Table 94. SK Chemicals Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. PLX Pharma Corporate Information, Location and Competitors
Table 96. PLX Pharma Piroxicam Major Business
Table 97. PLX Pharma Piroxicam Total Revenue (USD Million) (2017-2018)
Table 98. PLX Pharma SWOT Analysis
Table 99. PLX Pharma Piroxicam Product and Solutions
Table 100. PLX Pharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Genpharm Corporate Information, Location and Competitors
Table 102. Genpharm Piroxicam Major Business
Table 103. Genpharm Piroxicam Total Revenue (USD Million) (2017-2018)
Table 104. Genpharm SWOT Analysis
Table 105. Genpharm Piroxicam Product and Solutions
Table 106. Genpharm Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. CJ HealthCare Piroxicam Type and Application
Table 108. CJ HealthCare Piroxicam Major Business
Table 109. CJ HealthCare Piroxicam Total Revenue (USD Million) (2017-2018)
Table 110. CJ HealthCare SWOT Analysis
Table 111. CJ HealthCare Piroxicam Product and Solutions
Table 112. CJ HealthCare Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Bioglan Laboratories Corporate Information, Location and Competitors
Table 114. Bioglan Laboratories Piroxicam Major Business
Table 115. Bioglan Laboratories Piroxicam Total Revenue (USD Million) (2017-2018)
Table 116. Bioglan Laboratories SWOT Analysis
Table 117. Bioglan Laboratories Piroxicam Product and Solutions
Table 118. Bioglan Laboratories Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Bayer Corporate Information, Location and Competitors
Table 120. Bayer Piroxicam Major Business
Table 121. Bayer Piroxicam Total Revenue (USD Million) (2017-2018)
Table 122. Bayer SWOT Analysis
Table 123. Bayer Piroxicam Product and Solutions
Table 124. Bayer Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Changzhou Siyao Pharmaceutical Corporate Information, Location and Competitors
Table 126. Changzhou Siyao Pharmaceutical Piroxicam Major Business
Table 127. Changzhou Siyao Pharmaceutical Piroxicam Total Revenue (USD Million) (2017-2018)
Table 128. Changzhou Siyao Pharmaceutical SWOT Analysis
Table 129. Changzhou Siyao Pharmaceutical Piroxicam Product and Solutions
Table 130. Changzhou Siyao Pharmaceutical Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Shanxi Yunpeng Pharmaceutical Corporate Information, Location and Competitors
Table 132. Shanxi Yunpeng Pharmaceutical Piroxicam Major Business
Table 133. Shanxi Yunpeng Pharmaceutical Piroxicam Total Revenue (USD Million) (2017-2018)
Table 134. Shanxi Yunpeng Pharmaceutical SWOT Analysis
Table 135. Shanxi Yunpeng Pharmaceutical Piroxicam Product and Solutions
Table 136. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global Piroxicam Revenue (Million USD) by Players (2015-2020)
Table 138. Global Piroxicam Revenue Share by Players (2015-2020)
Table 139. Global Piroxicam Revenue (Million USD) by Regions (2015-2020)
Table 140. Global Piroxicam Revenue Market Share by Regions (2015-2020)
Table 141. North America Piroxicam Revenue by Countries (2015-2020)
Table 142. North America Piroxicam Revenue Market Share by Countries (2015-2020)
Table 143. Europe Piroxicam Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific Piroxicam Revenue (Million USD) by Countries (2015-2020)
Table 145. South America Piroxicam Revenue by Countries (2015-2020)
Table 146. South America Piroxicam Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa Piroxicam Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa Piroxicam Revenue Market Share by Countries (2015-2020)
Table 149. Global Piroxicam Revenue (Million USD) by Type (2015-2020)
Table 150. Global Piroxicam Revenue Share by Type (2015-2020)
Table 151. Global Piroxicam Revenue Forecast by Type (2021-2025)
Table 152. Global Piroxicam Revenue by Application (2015-2020)
Table 153. Global Piroxicam Revenue Share by Application (2015-2020)
Table 154. Global Piroxicam Revenue Forecast by Application (2021-2025)
Table 155. Global Piroxicam Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Piroxicam Picture
Figure 2. Global Piroxicam Revenue Market Share by Type in 2019
Figure 3. Suppositories Picture
Figure 4. Injection Picture
Figure 5. Capsule Picture
Figure 6. Patch Picture
Figure 7. Other Picture
Figure 8. Piroxicam Revenue Market Share by Application in 2019
Figure 9. Tendonitis Picture
Figure 10. Systemic Traumatic Pain Picture
Figure 11. Musculoskeletal Pain Picture
Figure 12. Contraception Picture
Figure 13. Rheumatoid Arthritis Picture
Figure 14. Chronic Infectious Arthritis Picture
Figure 15. Osteoarthritis Picture
Figure 16. Other Picture
Figure 17. Global Piroxicam Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. North America Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Europe Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. South America Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Middle East and Africa Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Piroxicam Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Piroxicam Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Piroxicam Revenue Market Share in 2019
Figure 26. Global Top 10 Players Piroxicam Revenue Market Share in 2019
Figure 27. Key Players Market Share Trend
Figure 28. Global Piroxicam Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 29. Global Piroxicam Revenue Market Share by Regions (2015-2020)
Figure 30. Global Piroxicam Revenue Market Share by Regions in 2018
Figure 31. North America Piroxicam Revenue and Growth Rate (2015-2020)
Figure 32. Europe Piroxicam Revenue and Growth Rate (2015-2020)
Figure 33. Asia-Pacific Piroxicam Revenue and Growth Rate (2015-2020)
Figure 34. South America Piroxicam Revenue and Growth Rate (2015-2020)
Figure 35. Middle East and Africa Piroxicam Revenue and Growth Rate (2015-2020)
Figure 36. North America Piroxicam Revenue Market Share by Countries (2015-2020)
Figure 37. North America Piroxicam Revenue Market Share by Countries in 2019
Figure 38. USA Piroxicam Revenue and Growth Rate (2015-2020)
Figure 39. Canada Piroxicam Revenue and Growth Rate (2015-2020)
Figure 40. Mexico Piroxicam Revenue and Growth Rate (2015-2020)
Figure 41. Europe Piroxicam Revenue Market Share by Countries (2015-2020)
Figure 42. Europe Piroxicam Revenue Market Share by Countries in 2019
Figure 43. Germany Piroxicam Revenue and Growth Rate (2015-2020)
Figure 44. UK Piroxicam Revenue and Growth Rate (2015-2020)
Figure 45. France Piroxicam Revenue and Growth Rate (2015-2020)
Figure 46. Russia Piroxicam Revenue and Growth Rate (2015-2020)
Figure 47. Italy Piroxicam Revenue and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Piroxicam Revenue Market Share by Countries (2015-2020)
Figure 49. Asia-Pacific Piroxicam Revenue Market Share by Countries in 2019
Figure 50. China Piroxicam Revenue and Growth Rate (2015-2020)
Figure 51. Japan Piroxicam Revenue and Growth Rate (2015-2020)
Figure 52. Korea Piroxicam Revenue and Growth Rate (2015-2020)
Figure 53. India Piroxicam Revenue and Growth Rate (2015-2020)
Figure 54. Southeast Asia Piroxicam Revenue and Growth Rate (2015-2020)
Figure 55. South America Piroxicam Revenue Market Share by Countries (2015-2020)
Figure 56. South America Piroxicam Revenue Market Share by Countries in 2019
Figure 57. Brazil Piroxicam Revenue and Growth Rate (2015-2020)
Figure 58. Argentina Piroxicam Revenue and Growth Rate (2015-2020)
Figure 59. Middle East and Africa Piroxicam Revenue Market Share by Countries (2015-2020)
Figure 60. Middle East and Africa Piroxicam Revenue Market Share by Countries in 2019
Figure 61. Saudi Arabia Piroxicam Revenue and Growth Rate (2015-2020)
Figure 62. UAE Piroxicam Revenue and Growth Rate (2015-2020)
Figure 63. Egypt Piroxicam Revenue and Growth Rate (2015-2020)
Figure 64. South Africa Piroxicam Revenue and Growth Rate (2015-2020)
Figure 65. Global Piroxicam Revenue Share by Type (2015-2020)
Figure 66. Global Piroxicam Revenue Share by Type in 2019
Figure 67. Global Piroxicam Market Share Forecast by Type (2021-2025)
Figure 68. Global Suppositories Revenue Growth Rate (2015-2020)
Figure 69. Global Injection Revenue Growth Rate (2015-2020)
Figure 70. Global Capsule Revenue Growth Rate (2015-2020)
Figure 71. Global Patch Revenue Growth Rate (2015-2020)
Figure 72. Global Other Revenue Growth Rate (2015-2020)
Figure 73. Global Piroxicam Revenue Share by Application (2015-2020)
Figure 74. Global Piroxicam Revenue Share by Application in 2019
Figure 75. Global Piroxicam Market Share Forecast by Application (2021-2025)
Figure 76. Global Tendonitis Revenue Growth Rate (2015-2020)
Figure 77. Global Systemic Traumatic Pain Revenue Growth Rate (2015-2020)
Figure 78. Global Musculoskeletal Pain Revenue Growth Rate (2015-2020)
Figure 79. Global Contraception Revenue Growth Rate (2015-2020)
Figure 80. Global Rheumatoid Arthritis Revenue Growth Rate (2015-2020)
Figure 81. Global Chronic Infectious Arthritis Revenue Growth Rate (2015-2020)
Figure 82. Global Osteoarthritis Revenue Growth Rate (2015-2020)
Figure 83. Global Other Revenue Growth Rate (2015-2020)
Figure 84. Global Piroxicam Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 85. Global Piroxicam Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 86. Global Piroxicam Revenue Market Share Forecast by Regions (2021-2025)
Figure 87. North America Piroxicam Revenue Market Forecast (2021-2025)
Figure 88. Europe Piroxicam Revenue Market Forecast (2021-2025)
Figure 89. Asia-Pacific Piroxicam Revenue Market Forecast (2021-2025)
Figure 90. South America Piroxicam Revenue Market Forecast (2021-2025)
Figure 91. Middle East and Africa Piroxicam Revenue Market Forecast (2021-2025)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
筋骨格系医療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Musculoskeletal Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Musculoskeletal Medi…- テトラカインの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tetracaine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetracaine market report provides …
- テトラカインの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tetracaine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetracaine market report provides …
- トラマドール（INN）の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Tramadol (INN) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tramadol (INN) market report p…
- 外傷性脳損傷（TBI）テストバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Traumatic Brain Injury (TBI) Testing Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…